SCHEMBL6137677

SCHEMBL6137677

O=C1Nc2cc(-c3ccco3)ccc2C2CCCC12F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 2/20 0.39
SRD5A1 P18405 2/20 0.38
ALOX5 P09917 1/20 0.34
NOS3 P29474 3/20 0.34
NOS1 P29475 3/20 0.34
NOS2 P35228 3/20 0.34
PGR P06401 1/20 0.34
RET P07949 1/20 0.34
KEAP1 Q14145 1/20 0.33
HTR7 P34969 1/20 0.33
CDK2 P24941 1/20 0.33
GSK3A P49840 1/20 0.33
MAPK14 Q16539 1/20 0.32
PIM1 P11309 1/20 0.32
ERN1 O75460 1/20 0.32
CHEK1 O14757 1/20 0.32
CYP2D6 P10635 1/20 0.32
RECQL P46063 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137634 0.75 NOS3 (0.48) NOS3NOS1NOS2HSD17B10
SCHEMBL6137425 0.74 NOS3 (0.59) TDP2SRD5A1NOS3NOS1NOS2
SCHEMBL6069508 0.72 TDP2 (0.42) TDP2SRD5A1ALOX5PGRRET
SCHEMBL6137774 0.72 NOS3 (0.39) NOS3NOS1NOS2
SCHEMBL6137525 0.71 NOS3 (0.41) NOS3NOS1NOS2
SCHEMBL6137757 0.70 GPR119 (0.41) SRD5A1HTR7
SCHEMBL6137662 0.70 NOS3 (0.34) NOS3NOS1NOS2PGR
SCHEMBL6137625 0.69 NOS3 (0.40) NOS3NOS1NOS2CHEK1
SCHEMBL6137746 0.68 NOS3 (0.55) NOS3NOS1NOS2PGRCHEK1
SCHEMBL6137467 0.68 POLB (0.43) NOS3NOS1NOS2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1129077-B9 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-07-20 EP disclosed
EP-1129077-B1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-04-20 EP disclosed
US-6579883-B1 Nitrogen monoxide synthases; 4-amino-8-bromo-3a-fluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta (c) quinoline; neurodegenerative, autoimmune, cardiovascular diseases SCHERING AKTIENGESELLSCHAFT (DE) 2003-06-17 US disclosed
EP-1129077-A1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2001-09-05 EP disclosed
WO-2000029381-A1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2000-05-25 WO disclosed